X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (398) 398
male (281) 281
female (268) 268
cardiac & cardiovascular systems (265) 265
middle aged (242) 242
aged (190) 190
mortality (119) 119
prognosis (104) 104
acute myocardial-infarction (96) 96
adult (90) 90
risk factors (89) 89
electrocardiography (87) 87
treatment outcome (86) 86
index medicus (75) 75
myocardial infarction - drug therapy (74) 74
follow-up studies (73) 73
myocardial infarction - mortality (68) 68
heart attacks (62) 62
coronary heart disease (61) 61
thrombolytic therapy (61) 61
cardiology (60) 60
risk (59) 59
myocardial infarction (58) 58
human (57) 57
time factors (53) 53
angioplasty (52) 52
risk assessment (51) 51
peripheral vascular disease (48) 48
unstable angina (48) 48
acute coronary syndromes (46) 46
cardiovascular disease (46) 46
drug therapy (46) 46
heart attack (46) 46
acute disease (44) 44
trial (44) 44
prospective studies (43) 43
myocardial infarction - therapy (42) 42
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (42) 42
survival analysis (42) 42
angioplasty, balloon, coronary (41) 41
cardiac patients (41) 41
myocardial-infarction (41) 41
platelet aggregation inhibitors - therapeutic use (40) 40
care and treatment (38) 38
health aspects (38) 38
thrombolysis (38) 38
clinical trials (36) 36
coronary angiography (36) 36
double-blind method (36) 36
myocardial infarction - diagnosis (36) 36
randomized controlled trials as topic (36) 36
abciximab (35) 35
clinical trials as topic (35) 35
coronary vessels (35) 35
medicine, general & internal (35) 35
syndrome (35) 35
survival rate (34) 34
medical and health sciences (33) 33
medicin och hälsovetenskap (33) 33
cardiovascular (32) 32
streptokinase (32) 32
cardiology and cardiovascular medicine (31) 31
recurrence (31) 31
streptokinase - therapeutic use (31) 31
exercise test (30) 30
fibrinolytic agents - therapeutic use (30) 30
medicine (30) 30
predictive value of tests (30) 30
therapy (30) 30
coronary artery disease (28) 28
myocardial infarction - physiopathology (28) 28
patient outcomes (28) 28
stroke (27) 27
angina, unstable - drug therapy (26) 26
coronary artery bypass (26) 26
medical research (26) 26
reperfusion (26) 26
retrospective studies (26) 26
angiotensin-converting enzyme inhibitors - therapeutic use (25) 25
diagnosis (25) 25
heart failure (25) 25
management (25) 25
antibodies, monoclonal - therapeutic use (24) 24
c-reactive protein (24) 24
incidence (24) 24
0 (23) 23
abridged index medicus (23) 23
analysis (23) 23
coronary disease - diagnosis (23) 23
follow-up (23) 23
immunoglobulin fab fragments - therapeutic use (23) 23
ischemia (23) 23
multivariate analysis (23) 23
myocardial infarction - blood (23) 23
myocardial infarction - complications (23) 23
biomarkers - blood (22) 22
coronary artery disease - drug therapy (22) 22
disease (22) 22
echocardiography (22) 22
heart-failure (22) 22
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CIRCULATION, ISSN 0009-7322, 09/2006, Volume 114, Issue 11, pp. F141 - F142
Journal Article
European Heart Journal, ISSN 0195-668X, 03/2016, Volume 37, Issue 9, pp. 730 - 730
Journal Article
ACC Current Journal Review, ISSN 1062-1458, 2003, Volume 12, Issue 3, pp. 12 - 13
textabstractBACKGROUND: CD40 ligand is expressed on platelets and released from them on activation. We investigated the predictive value of soluble CD40 ligand... 
Acute Disease | Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors | Prognosis | Follow-Up Studies | Platelet Aggregation Inhibitors/therapeutic use | CD40 Ligand/blood | Humans | Risk Factors | Angina Pectoris/blood/drug therapy | Antibodies, Monoclonal/therapeutic use | Male | Treatment Outcome | Immunoglobulin Fab Fragments/therapeutic use | Biological Markers/blood | Randomized Controlled Trials | Platelet Activation | Middle aged | Research Support, Non-U.S. Gov't | Survival Analysis | Female | Myocardial Infarction/blood/drug therapy | MEDICINE, GENERAL & INTERNAL | ACTIVATION | TROPONIN-I PREDICTS | REFRACTORY UNSTABLE ANGINA | T LEVELS | ENDOTHELIAL-CELLS | ACUTE MYOCARDIAL-INFARCTION | P-SELECTIN | RISK | PROGNOSTIC VALUE | TISSUE FACTOR | Myocardial Infarction - blood | CD40 Ligand - blood | Middle Aged | Angina Pectoris - drug therapy | Antibodies, Monoclonal - therapeutic use | Biomarkers - blood | Immunoglobulin Fab Fragments - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Randomized Controlled Trials as Topic | Angina Pectoris - blood | Myocardial Infarction - drug therapy | Platelet Aggregation Inhibitors - therapeutic use | Physiological aspects | Coronary heart disease | Health aspects | Ligands (Biochemistry) | Heart attack | Risk factors | Cardiovascular disease | Heart attacks | Angina pectoris | Coronary vessels
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 13, pp. 1206 - 1214
Journal Article
European heart journal, 03/2016, Volume 37, Issue 9, p. 730
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 16, pp. 1581 - 1598
Journal Article
by Thygesen, Kristian and Alpert, Joseph S and Jaffe, Allan S and Simoons, Maarten L and Chaitman, Bernard R and White, Harvey D and Katus, Hugo A and Apple, Fred S and Lindahl, Bertil and Morrow, David A and Clemmensen, Peter M and Johanson, Per and Hod, Hanoch and Underwood, Richard and Bax, Jeroen J and Bonow, Robert O and Pinto, Fausto and Gibbons, Raymond J and Fox, Keith A and Atar, Dan and Newby, L. Kristin and Galvani, Marcello and Hamm, Christian W and Uretsky, Barry F and Steg, Ph. Gabriel and Wijns, William and Bassand, Jean-Pierre and Menasché, Phillippe and Ravkilde, Jan and Ohman, E. Magnus and Antman, Elliott M and Wallentin, Lars C and Armstrong, Paul W and Simoon, Maarten L and Januzzi, James L and Nieminen, Markku S and Gheorghiade, Mihai and Filippatos, Gerasimos and Luepker, Russell V and Fortmann, Stephen P and Rosamond, Wayne D and Levy, Dan and Wood, David and Smith, Sidney C and Hu, Dayi and Lopez-Sendon, José-Luis and Robertson, Rose Marie and Weaver, Douglas and Tendera, Michal and Bove, Alfred A and Parkhomenko, Alexander N and Vasilieva, Elena J and Mendis, Shanti and Baumgartner, Helmut and Ceconi, Claudio and Dean, Veronica and Deaton, Christi and Fagard, Robert and Funck-Brentano, Christian and Hasdai, David and Hoes, Arno and Kirchhof, Paulus and Knuuti, Juhani and Kolh, Philippe and McDonagh, Theresa and Moulin, Cyril and Popescu, Bogdan A and Reiner, Željko and Sechtem, Udo and Sirnes, Per Anton and Torbicki, Adam and Vahanian, Alec and Windecker, Stephan and Morais, Joao and Aguiar, Carlos and Almahmeed, Wael and Arnar, David O and Barili, Fabio and Bloch, Kenneth D and Bolger, Ann F and Bøtker, Hans Erik and Bozkurt, Biykem and Bugiardini, Raffaele and Cannon, Christopher and De Lemos, James and Eberli, Franz R and Escobar, Edgardo and Hlatky, Mark and James, Stefan and Kern, Karl B and Moliterno, David J and Mueller, Christian and Neskovic, Aleksandar N and Pieske, Burkert Mathias and Schulman, Steven P and Storey, Robert F and Taubert, Kathryn A and Vranckx, Pascal and Wagner, Daniel R and Joint ESC ACCF AHA WHF Task and Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
Circulation, ISSN 0009-7322, 10/2012, Volume 126, Issue 16, pp. 2020 - 2035
Journal Article
1984, Developments in cardiovascular medicine, ISBN 0898385997, Volume 32, x, 255
Book
PLoS ONE, ISSN 1932-6203, 2014, Volume 9, Issue 8, p. e103978
To investigate the effects of inotropic agents on parameters of tissue perfusion in patients with cardiogenic shock. Thirty patients with cardiogenic shock... 
SUPPORT | MULTIDISCIPLINARY SCIENCES | NITROGLYCERIN | SEPTIC SHOCK | MICROCIRCULATION | INHIBITORS | BLOOD-FLOW | ASSOCIATION | SEVERE HEART-FAILURE | Norepinephrine - pharmacology | Myocardial Infarction - mortality | Humans | Middle Aged | Shock, Cardiogenic - mortality | Norepinephrine - administration & dosage | Capillaries - drug effects | Male | Shock, Cardiogenic - physiopathology | Microcirculation - drug effects | Aged, 80 and over | Female | Myocardial Infarction - physiopathology | Enoximone - administration & dosage | Resuscitation | Capillaries - physiopathology | Shock, Cardiogenic - complications | Treatment Outcome | Dobutamine - administration & dosage | Dobutamine - pharmacology | Myocardial Infarction - complications | Enoximone - pharmacology | Perfusion | Aged | Hemodynamics - drug effects | Pulmonary Circulation - drug effects | Medical research | Care and treatment | Cardiotonic agents | Cardiogenic shock | Mortality | Medicine, Experimental | Dobutamine | Health aspects | Noradrenaline | Cardiac glycosides | Myocardial infarction | Shock | Intensive care | Heart attacks | Oxygen content | Optimization | Blood pressure | Cardiology | Heart diseases | Heart failure | Departments | Parameters | Pulmonary arteries | Therapeutic applications | Multiple organ dysfunction syndrome | Temperature gradients | Saturation | Patients | Catheters | Temperature gradient | Medicine | Sepsis | Titration | Infarction | Norepinephrine | Skin | Hemodynamics | Veins & arteries
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 5, pp. 788 - 794
Journal Article
by Thygesen, Kristian and Alpert, Joseph S and White, Harvey D and ESC ACCF AHA WHF Task Force and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction and Biomarker Group: Allan S. Jaffe, Coordinator (USA), Fred S. Apple (USA), Marcello Galvani (Italy), Hugo A. Katus (Germany), L. Kristin Newby (USA), Jan Ravkilde (Denmark) and ECG Group: Bernard Chaitman, Co-ordinator (USA), Peter M. Clemmensen (Denmark), Mikael Dellborg (Sweden), Hanoch Hod (Israel), Pekka Porela (Finland) and Global Perspective Group: Philip A. Poole-Wilson, Coordinator (UK), Enrique P. Gurfinkel (Argentina), José-Luis Lopez-Sendon (Spain), Prem Pais (India), Shanti Mendis (Switzerland), Jun-Ren Zhu (China) and ESC COMMITTEE FOR PRACTICE GUIDELINES and Implementation Group: Lars C. Wallentin Coordinator (Sweden), Francisco Fernández-Avilés (Spain), Kim M. Fox (UK), Alexander N. Parkhomenko (Ukraine), Silvia G. Priori (Italy), Michal Tendera (Poland), Liisa-Maria Voipio-Pulkki (Finland) and Imaging Group: Richard Underwood, Coordinator (UK), Jeroen J. Bax (The Netherlands), George A. Beller (USA), Robert Bonow (USA), Ernst E. Van Der Wall (The Netherlands) and Joao Morais, Review Coordinator (Portugal), Sorin Brener (USA), Robert Harrington (USA), David Morrow (USA), Udo Sechtem (Germany), Michael Lim (Singapore), Marco A. Martinez-Rios (Mexico), Steve Steinhubl (USA), Glen N. Levine (USA), W. Brian Gibler (USA), David Goff (USA), Marco Tubaro (Italy), Darek Dudek (Poland), Nawwar Al-Attar (France) and Alec Vahanian, Chair (France), A. John Camm (UK), Raffaele De Caterina (Italy), Veronica Dean (France), Kenneth Dickstein (Norway), Gerasimos Filippatos (Greece), Christian Funck-Brentano (France), Irene Hellemans (The Netherlands), Steen Dalby Kristensen (Denmark), Keith McGregor (France), Udo Sechtem (Germany), Sigmund Silber (Germany), Michal Tendera (Poland), Petr Widimsky (Czech Republic), José Luis Zamorano (Spain) and TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), Joseph S. Alpert (USA), Harvey D. White (New Zealand) and Intervention Group: Jean-Pierre Bassand, Co-ordinator (France), William Wijns, Coordinator (Belgium), T. Bruce Ferguson (USA), Philippe G. Steg (France), Barry F. Uretsky (USA), David O. Williams (USA) and Clinical Investigation Group: Paul W. Armstrong, Coordinator (Canada), Elliott M. Antman (USA), Keith A. Fox (UK), Christian W. Hamm (Germany), E. Magnus Ohman (USA), Maarten L. Simoons (The Netherlands) and DOCUMENT REVIEWERS and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper
Circulation, ISSN 0009-7322, 11/2007, Volume 116, Issue 22, pp. 2634 - 2653
Journal Article